New drug combo aims to boost Life-Saving stem cell harvest for cancer patients
NCT ID NCT06514508
Summary
This study is testing whether adding a new drug called motixafortide to a standard treatment (G-CSF) helps collect more stem cells from patients with multiple myeloma. These stem cells are needed for a transplant procedure that can help control the cancer. The trial will compare the new combination against the standard treatment alone in 60 Chinese patients to see if it's more effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harbin The First Hospital
NOT_YET_RECRUITINGHarbin, Hei Longjiang, 150010, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.